 NEW YORK, NY ACCESSWIRE April 26, 2022 Protagenic Therapeutics, Inc. NASDAQ:PTIX a biopharmaceutical company focused on developing drug product candidates to treat stress-related neurologic disorders, today announced will be presenting at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference tomorrow, April 27, 2022. 